Enoxaparin combined with epitfibatide or abciximab versus unfractionated heparin combined with epitfibatide or abciximab in percutaneous coronary intervention: obersvations on efficacy, safety, anticoagulation profile, and level of platelet inhibition
Grant Data
Project Title
Enoxaparin combined with epitfibatide or abciximab versus unfractionated heparin combined with epitfibatide or abciximab in percutaneous coronary intervention: obersvations on efficacy, safety, anticoagulation profile, and level of platelet inhibition
Principal Investigator
Dr Chen, Wai Hong
(Principal Investigator (PI))
Co-Investigator(s)
Professor Lau Chu Pak
(Co-Investigator)
Duration
12
Start Date
2001-06-20
Amount
0
Conference Title
Enoxaparin combined with epitfibatide or abciximab versus unfractionated heparin combined with epitfibatide or abciximab in percutaneous coronary intervention: obersvations on efficacy, safety, anticoagulation profile, and level of platelet inhibition
Presentation Title
Keywords
null
Discipline
N/A
HKU Project Code
N/A
Grant Type
Other Funding Scheme
Funding Year
2000
Status
Completed
Objectives
To compare the safety, efficacy, anticoagulation profile and level of platelet inhibition in patients undergoing percutaneous coronary intervention using enoxaparin/eptifibatide, unfractionated heparin/epitfibatide, enoxaparin/abciximab, and unfractionated heparin/abciximab.